|
1
|
Menter A, Gottlieb A, Feldman SR, Van
Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA,
Korman NJ, et al: Guidelines of care for the management of
psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis
and guidelines of care for the treatment of psoriasis with
biologics. J Am Acad Dermatol. 58:826–850. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin AM, Rubin CJ, Khandpur R, Wang JY,
Riblett M, Yalavarthi S, Villanueva EC, Shah P, Kaplan MJ and Bruce
AT: Mast cells and neutrophils release IL-17 through extracellular
trap formation in psoriasis. J Immunol. 187:490–500. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carey W, Glazer S, Gottlieb AB, Lebwohl M,
Leonardi C, Menter A, Papp K, Rundle AC and Toth D: Relapse,
rebound, and psoriasis adverse events: An advisory group report. J
Am Acad Dermatol. 54 4 Suppl 1:S171–S181. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Menter A and Griffiths CE: Current and
future management of psoriasis. Lancet. 370:272–284. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sala M, Elaissari A and Fessi H: Advances
in psoriasis physiopathology and treatments: Up to date of
mechanistic insights and perspectives of novel therapies based on
innovative skin drug delivery systems (ISDDS). J Control Release.
239:182–202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choonhakarn C, Busaracome P,
Sripanidkulchai B and Sarakarn P: A prospective, randomized
clinical trial comparing topical aloe vera with 0.1% triamcinolone
acetonide in mild to moderate plaque psoriasis. J Eur Acad Dermatol
Venereol. 24:168–172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Das S, Mishra B, Gill K, Ashraf MS, Singh
AK, Sinha M, Sharma S, Xess I, Dalal K, Singh TP and Dey S:
Isolation and characterization of novel protein with anti-fungal
and anti-inflammatory properties from Aloe vera leaf gel. Int J
Biol Macromol. 48:38–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Davis RH, DiDonato JJ, Johnson RW and
Stewart CB: Aloe vera, hydrocortisone, and sterol influence on
wound tensile strength and anti-inflammation. J Am Podiatr Med
Assoc. 84:614–621. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baradaran A, Nasri H, Nematbakhsh M and
Rafieian-Kopaei M: Antioxidant activity and preventive effect of
aqueous leaf extract of Aloe Vera on gentamicin-induced
nephrotoxicity in male Wistar rats. Clin Ter. 165:7–11.
2014.PubMed/NCBI
|
|
10
|
Seyger MM, van de Kerkhof PC, van
Vlijmen-Willems IM, de Bakker ES, Zwiers F and de Jong EM: The
efficacy of a new topical treatment for psoriasis: Mirak. J Eur
Acad Dermatol Venereol. 11:13–18. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Paulsen E, Korsholm L and Brandrup F: A
double-blind, placebo-controlled study of a commercial Aloe vera
gel in the treatment of slight to moderate psoriasis vulgaris. J
Eur Acad Dermatol Venereol. 19:326–331. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yarilina A, Park-Min KH, Antoniv T, Hu X
and Ivashkiv LB: TNF activates an IRF1-dependent autocrine loop
leading to sustained expression of chemokines and STAT1-dependent
type I interferon-response genes. Nat Immunol. 9:378–387. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gibellini L, De Biasi S, Bianchini E,
Bartolomeo R, Fabiano A, Manfredini M, Ferrari F, Albertini G,
Trenti T, Nasi M, et al: Anti-TNF-α drugs differently affect the
TNFα-sTNFR system and monocyte subsets in patients with psoriasis.
PLoS One. 11:e01677572016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miroddi M, Navarra M, Calapai F, Mancari
F, Giofrè SV, Gangemi S and Calapai G: Review of clinical
pharmacology of Aloe vera L. in the treatment of psoriasis.
Phytother Res. 29:648–655. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dhanabal SP, Dwarampudi Priyanka L,
Muruganantham N and Vadivelan R: Evaluation of the antipsoriatic
activity of Aloe vera leaf extract using mouse tail model
psoriasis. Phytother Res. 26:617–619. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Baldwin AS Jr: The NF-kappa B and I kappa
B proteins: New discoveries and insights. Annu Rev Immunol.
14:649–683. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tak PP and Firestein GS: NF-kappaB: A key
role in inflammatory diseases. J Clin Invest. 107:7–11. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lizzul PF, Aphale A, Malaviya R, Sun Y,
Masud S, Dombrovskiy V and Gottlieb AB: Differential expression of
phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and
downregulation of NF-kappaB in response to treatment with
etanercept. J Invest Dermatol. 124:1275–1283. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vijayalakshmi D, Dhandapani R, Jayaveni S,
Jithendra PS, Rose C and Mandal AB: In vitro anti inflammatory
activity of Aloe vera by down regulation of MMP-9 in peripheral
blood mononuclear cells. J Ethnopharmacol. 141:542–546. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lima JF, Carvalho J, Pinto-Ribeiro I,
Almeida C, Wengel J, Cerquera L, Figueiredo C, Oliveira C and
Azevedo NF: Targeting miR-9 in gastric cancer cells using locked
nucleic acid oligonucleotides. BMC Mol Biol. 19:62018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mizuno K, Morizane S, Takiguchi T and
Iwatsuki K: Dexamethasone but not tacrolimus suppresses
THF-α-induced thymic stromal lymphopoitin expression in lesional
keratinocytes of atopic dermatitis model. J Dermatol Sci. 80:45–53.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kyle S, Chandler D, Griffiths CE,
Helliwell P, Lewis J, McInnes I, Oliver S, Symmons D and McHugh N:
British Society for Rheumatology Standards Guidelines Audit Working
Group (SGAWG): Guideline for anti-TNF-alpha therapy in psoriatic
arthritis. Rheumatology (Oxford). 44:390–397. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lowes MA, Bowcock AM and Krueger JG:
Pathogenesis and therapy of psoriasis. Nature. 445:866–873. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan S, Xu Z, Lou F, Zhang L, Ke F, Bai J,
Liu Z, Liu J, Wang H, Zhu H, et al: NF-κB-induced microRNA-31
promotes epidermal hyperplasia by repressing protein phosphatase 6
in psoriasis. Nat Commun. 6:76522015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deng S, May BH, Zhang AL, Lu C and Xue CC:
Plant extracts for the topical management of psoriasis: A
systematic review and meta-analysis. Br J Dermatol. 169:769–782.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sato K, Takaishi M, Tokuoka S and Sano S:
Involvement of TNF-α converting enzyme in the development of
psoriasis-like in a mose model. PLoS One. 9:e1124082014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gudjonsson JE, Johnston A, Sigmundsdottir
H and Valdimarsson H: Immunopathogenic mechanisms in psoriasis.
Clin Exp Immunol. 135:1–8. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sidhom E, Pilmane M and Kisis J: Local
antimicrobial, protease and cytokine defense systems in psoriatic
skin. Indian J Dermatol Venereol Leprol. 82:284–291. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kauffman CL, Aria N, Toichi E, McCormick
TS, Cooper KD, Gottlieb AB, Everitt DE, Frederick B, Zhu Y, Graham
MA, et al: A phase I study evaluating the safety, pharmacokinetics,
and clinical response of a human IL-12 p40 antibody in subjects
with plaque psoriasis. J Invest Dermatol. 123:1037–1044. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chandel NS, Trzyna WC, McClintock DS and
Schumacker PT: Role of oxidants in NF-kappa B activation and
TNF-alpha gene transcription induced by hypoxia and endotoxin. J
Immunol. 165:1013–1021. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bouwmeester T, Bauch A, Ruffner H, Angrand
PO, Bergamini G, Croughton K, Cruciat C, Eberhard D, Gagneur J,
Ghidelli S, et al: A physical and functional map of the human
TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol.
6:97–105. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Baeuerle PA and Henkel T: Function and
activation of NF-kappa B in the immune system. Annu Rev Immunol.
12:141–179. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Goldminz AM, Au SC, Kim N, Gottlieb AB and
Lizzul PF: NF-kappaB: An essential transcription factor in
psoriasis. J Dermatol Sci. 69:89–94. 2013. View Article : Google Scholar : PubMed/NCBI
|
